Jenken Biosciences Company
Jenken Biosciences is a specialty dedicated to the development and commercialization of first-in-class small molecules as TLR4 antagonists.
Technology:
Data-driven Technologies
Industry:
PharmTech
Headquarters:
Durham, North Carolina, United States
Founded Date:
2003
Employees Number:
1-10
Estimated Revenue:
$1M to $10M
Register and Claim Ownership